Review, 2024

Terminating Corticosteroid Injection in Tendinopathy? Hasta la Vista, Baby

Journal of Orthopaedic and Sports Physical Therapy, ISSN 0190-6011, Volume 54, 1, Pages 10-13, 10.2519/jospt.2023.11875

Contributors

Visser T.S.S. 0000-0002-4483-1936 [1] Linschoten R.V. [1] [2] Vicenzino B. 0000-0003-0253-5933 [3] Weir A. 0000-0003-0861-662X [1] De Vos R.-J. 0000-0003-0372-0188 [1]

Affiliations

  1. [1] Erasmus MC
  2. [NORA names: Netherlands; Europe, EU; OECD];
  3. [2] Billeddiagnostisk Afsnit, Regionshospital Nordjylland
  4. [NORA names: North Denmark Region; Hospital; Denmark; Europe, EU; Nordic; OECD];
  5. [3] University of Queensland
  6. [NORA names: Australia; Oceania; OECD]

Abstract

t SYNOPSIS: Two recent randomized-controlled trials showed promising results of local corticosteroid injections combined with exercise therapy for Achilles tendinopathy and plantar fasciopathy. Should clinicians go back to using corticosteroid injections to treat tendinopathy? Are corticosteroids back (baby)? In this viewpoint we critically appraise the new evidence and humbly share our clinical reasoning when advising athletes about corticosteroid injections in practice. Our goal is to help clinicians decide what to do and what to recommend to patients. We prioritize the risk for higher recurrence rates and tendon rupture when weighing the reasonable treatment options for tendinopathy, and recommend against using corticosteroid injections. The best systematic review evidence shows that local corticosteroid injections are not effective for tendinopathies after the first few weeks, and produce worse long-term outcomes compared to other treatments. For now, we consider corticosteroid injections remain terminated. J Orthop Sports Phys Ther 2024;54(1):10-13. Epub 11 August 2023. doi:10.2519/jospt.2023.11875

Keywords

Achilles, RCT, injection therapy, plantar fasciopathy, risk of bias

Data Provider: Elsevier